128 related articles for article (PubMed ID: 20013845)
1. In reference to Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis.
Preuss SF; Quante G
Laryngoscope; 2010 Mar; 120(3):650; author reply 651. PubMed ID: 20013845
[No Abstract] [Full Text] [Related]
2. Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis.
Lott DG; Krakovitz PR
Laryngoscope; 2009 Mar; 119(3):567-70. PubMed ID: 19235765
[TBL] [Abstract][Full Text] [Related]
3. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.
Shehab N; Sweet BV; Hogikyan ND
Pharmacotherapy; 2005 Jul; 25(7):977-89. PubMed ID: 16006276
[TBL] [Abstract][Full Text] [Related]
4. Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis.
Broekema FI; Dikkers FG
Eur Arch Otorhinolaryngol; 2008 Aug; 265(8):871-9. PubMed ID: 18458927
[TBL] [Abstract][Full Text] [Related]
5. Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®).
Tjon Pian Gi RE; Dietz A; Djukic V; Eckel HE; Friedrich G; Golusinski W; Hantzakos A; Lawson G; Remacle M; Rihkanen H; Dikkers FG
Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):361-2. PubMed ID: 22020697
[No Abstract] [Full Text] [Related]
6. Delivery of cidofovir to respiratory papillomas of the distal trachea.
Cullen RD; Zdanski C
Laryngoscope; 2005 Mar; 115(3):552-4. PubMed ID: 15744176
[No Abstract] [Full Text] [Related]
7. Serial office-based intralesional injection of cidofovir in adult-onset recurrent respiratory papillomatosis.
Co J; Woo P
Ann Otol Rhinol Laryngol; 2004 Nov; 113(11):859-62. PubMed ID: 15562893
[TBL] [Abstract][Full Text] [Related]
8. Adult intralesional cidofovir therapy for laryngeal papilloma: a 10-year perspective.
Tanna N; Sidell D; Joshi AS; Bielamowicz SA
Arch Otolaryngol Head Neck Surg; 2008 May; 134(5):497-500. PubMed ID: 18490570
[TBL] [Abstract][Full Text] [Related]
9. [Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results].
Neumann K; Pudszuhn A; Welzel C; Bartel-Friedrich S; Passmann M
Laryngorhinootologie; 2003 Oct; 82(10):700-6. PubMed ID: 14593568
[TBL] [Abstract][Full Text] [Related]
10. Urrets-Zavalia syndrome as a complication of ocular hypotonia due to intravenous cidofovir treatment.
Orssaud C; Wermert D; Roux A; Laccourreye O; Sors H; Roche O; Dufier JL
Eye (Lond); 2014 Jun; 28(6):776-7. PubMed ID: 24675584
[No Abstract] [Full Text] [Related]
11. Successful treatment of severe respiratory papillomatosis with intravenous cidofovir and interferon alpha-2b.
Armbruster C; Kreuzer A; Vorbach H; Huber M; Armbruster C
Eur Respir J; 2001 Apr; 17(4):830-1. PubMed ID: 11401080
[TBL] [Abstract][Full Text] [Related]
12. Office-based intralesional cidofovir injections for nasal septal papilloma: a pilot study.
Shemen LJ; Shnayder Y
Otolaryngol Head Neck Surg; 2006 Jul; 135(1):149-51. PubMed ID: 16815201
[TBL] [Abstract][Full Text] [Related]
13. CR12/339--Nebulized cidofovir for recurrent respiratory papillomatosis: a case report.
Giles BL; Seifert B
Paediatr Respir Rev; 2006; 7 Suppl 1():S330. PubMed ID: 17036412
[No Abstract] [Full Text] [Related]
14. Intralesional cidofovir for pediatric recurrent respiratory papillomatosis.
Mandell DL; Arjmand EM; Kay DJ; Casselbrant ML; Rosen CA
Arch Otolaryngol Head Neck Surg; 2004 Nov; 130(11):1319-23. PubMed ID: 15545589
[TBL] [Abstract][Full Text] [Related]
15. Mucosal bridge and pitting of the true vocal fold: an unusual complication of cidofovir injection.
Man LX; Statham MM; Rosen CA
Ann Otol Rhinol Laryngol; 2010 Apr; 119(4):236-8. PubMed ID: 20433022
[TBL] [Abstract][Full Text] [Related]
16. A scheduled protocol for the treatment of juvenile recurrent respiratory papillomatosis with intralesional cidofovir.
Chhetri DK; Shapiro NL
Arch Otolaryngol Head Neck Surg; 2003 Oct; 129(10):1081-5. PubMed ID: 14568791
[TBL] [Abstract][Full Text] [Related]
17. Is intralesional cidofovir worthwhile in juvenile recurrent respiratory papillomatosis?
Sheahan P; Sexton S; Russell JD
J Laryngol Otol; 2006 Jul; 120(7):561-5. PubMed ID: 16834805
[TBL] [Abstract][Full Text] [Related]
18. [The schedule of intralesional papillomatosis treatment with cidofovir].
Szyfter W; Wierzbicka M; Jackowska J; Bartochowska A; Banaszewski J
Otolaryngol Pol; 2010; 64(2):98-102. PubMed ID: 20568538
[TBL] [Abstract][Full Text] [Related]
19. 3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis.
Chung BJ; Akst LM; Koltai PJ
Int J Pediatr Otorhinolaryngol; 2006 Nov; 70(11):1911-7. PubMed ID: 16919339
[TBL] [Abstract][Full Text] [Related]
20. Intralesional cidofovir does not increase the risk of laryngeal dysplasia or laryngeal carcinoma.
Dikkers FG
Int J Pediatr Otorhinolaryngol; 2008 Oct; 72(10):1581-2; author reply 1583. PubMed ID: 18602168
[No Abstract] [Full Text] [Related]
[Next] [New Search]
